Literature DB >> 34393240

[Effect of topical injection of cyclosporine A on saliva secretion and inflammation in the submandibular gland of non-obese diabetic mice].

Y Y Zhu1, S N Min1, G Y Yu1.   

Abstract

OBJECTIVE: To investigate the effects of topical administration of cyclosporine A (CsA) on salivary secretion and inflammation of the submandibular glands in non-obese diabetic (NOD) mice.
METHODS: Female NOD mice, 21 aged 14 weeks and 18 aged 21 weeks were selected and randomly divided into low-dose group, high-dose group and control group on average. CsA was injected into submandibular glands. One week later the saliva stimulated by pilocarpine was collected and measured. The submandibular glands were collected to make paraffin sections. The lymphocyte infiltration in submandi-bular gland was observed by microscope after hematoxylin-eosin (HE) staining. The number of lymphocyte infiltration foci was counted to calculate the focus sore and the ratio of lymphocyte infiltration area to total gland area was figured up by Leica image analysis system. The expressions of inflammatory cytokines tumor necrosis factor-α (TNF-α), interferon-γ (IFN-γ), interleukin-4 (IL-4), IL-13, IL-17F, IL22 and IL-23a in the submandibular glands of the NOD mice were detected by quantitative real-time polymerase chain reaction (qRT-PCR). Cell apoptosis in the submandibular gland was detected by terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL). The levels of serum creatinine (Scr), blood urea nitrogen (BUN), uric acid (UA), alanine aminotransferase (ALT), aspertate aminotransferase (AST), alkaline phosphatase (ALP), albumin (ALB) and γ-glutamyl transferase (GGT) were measured by automatic biochemical analyzer to evaluate liver and kidney functions.
RESULTS: After topical injection of CsA in the submandibular gland, the stimulated salivary flow rate of the 14- and 21-week-old NOD mice significantly increased compared with the control group (P < 0.01 or P < 0.05), and the number and area of lymphocyte infiltration foci in the 14-week-old NOD mice low-dose group significantly decreased compared with the control group (P < 0.01). Low and high dose of CsA had similar effects on reducing inflammation and improving salivary secretion. The overall level of inflammatory cytokines in the submandibular gland did not decrease significantly. The number of cell apoptosis of submandibular gland in the NOD mice treated with CsA decreased compared with the control group, but there was no statistically significant difference. Topical injection of CsA had no adverse effect on liver and kidney function in the NOD mice.
CONCLUSION: Topical injection of CsA can reduce lymphocyte infiltration in submandibular gland of NOD mice and improve salivary secretion.

Entities:  

Keywords:  Sjögren's syndrome; cyclosporine A; non-obese diabetic mice; salivary gland; submandibular gland

Mesh:

Substances:

Year:  2021        PMID: 34393240      PMCID: PMC8365053     

Source DB:  PubMed          Journal:  Beijing Da Xue Xue Bao Yi Xue Ban        ISSN: 1671-167X


  18 in total

1.  Effect of topical 0.05% cyclosporine A on the tear protein lacritin in a rat model of dry eye.

Authors:  Fen-Dui Zhang; Zhao-Qin Hao; Wei Gao; Yi-Qiao Xing
Journal:  Int J Ophthalmol       Date:  2019-02-18       Impact factor: 1.779

2.  Spontaneous Model of Sjögren's Syndrome in NOD Mice.

Authors:  Monika D Scuron; Brittany Fay; Julian Oliver; Paul Smith
Journal:  Curr Protoc Pharmacol       Date:  2019-09

Review 3.  Treatment of primary Sjögren syndrome.

Authors:  Alain Saraux; Jacques-Olivier Pers; Valérie Devauchelle-Pensec
Journal:  Nat Rev Rheumatol       Date:  2016-07-14       Impact factor: 20.543

4.  Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test (OGTT) and Insulin Tolerance Test (ITT).

Authors:  Csörsz Nagy; Elisa Einwallner
Journal:  J Vis Exp       Date:  2018-01-07       Impact factor: 1.355

Review 5.  Treatment of primary Sjögren syndrome: a systematic review.

Authors:  Manuel Ramos-Casals; Athanasios G Tzioufas; John H Stone; Antoni Sisó; Xavier Bosch
Journal:  JAMA       Date:  2010-07-28       Impact factor: 56.272

Review 6.  Cytokine markers of B lymphocytes in minor salivary gland infiltrates in Sjögren's syndrome.

Authors:  Erika P Navarro-Mendoza; David Aguirre-Valencia; Iván Posso-Osorio; Shirley Vanessa Correa-Forero; Daniel-Felipe Torres-Cutiva; Diana Loaiza; Gabriel J Tobón
Journal:  Autoimmun Rev       Date:  2018-05-03       Impact factor: 9.754

Review 7.  Cyclosporin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic use in immunoregulatory disorders.

Authors:  Diana Faulds; Karen L Goa; Paul Benfield
Journal:  Drugs       Date:  1993-06       Impact factor: 9.546

Review 8.  Cyclosporine: mechanisms of action and toxicity.

Authors:  R M Graham
Journal:  Cleve Clin J Med       Date:  1994 Jul-Aug       Impact factor: 2.321

9.  Modulation of Inflammation-Related Genes in the Cornea of a Mouse Model of Dry Eye upon Treatment with Cyclosporine Eye Drops.

Authors:  Philippe Daull; Stefano Barabino; Laurence Feraille; Karima Kessal; Mylene Docquier; Stephane Melik Parsadaniantz; Christophe Baudouin; Jean-Sébastien Garrigue
Journal:  Curr Eye Res       Date:  2019-01-21       Impact factor: 2.424

10.  The effect of interleukin-22 treatment on autoimmune diabetes in the NOD mouse.

Authors:  Danielle J Borg; Ran Wang; Lydia Murray; Hui Tong; Raymond J Steptoe; Michael A McGuckin; Sumaira Z Hasnain
Journal:  Diabetologia       Date:  2017-08-04       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.